Oncolytic adenovirus targeting TGF-β enhances anti-tumor responses of mesothelin-targeted chimeric antigen receptor T cell therapy against breast cancer

Authors: Yuxiang Li, Fengjun Xiao, Aimei Zhang, Dan Zhang, Wenbo Nie, Tianxin Xu, Bing Han, Prem Seth, Hua Wang, Yuefeng Yang & Lisheng Wang

Citation: Li, Y., Fengjun, X., Zhang, D. et al. Oncolytic adenovirus targeting TGF-β enhances anti-tumor responses of mesothelin-targeted chimeric antigen receptor T cell therapy against breast cancer. Cell Immunol. (2020). https://doi.org/10.1016/j.cellimm.2020.104041